SCUTERI, Damiana
 Distribuzione geografica
Continente #
AS - Asia 2.142
NA - Nord America 1.988
EU - Europa 1.009
SA - Sud America 529
AF - Africa 150
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.828
Nazione #
US - Stati Uniti d'America 1.885
SG - Singapore 941
CN - Cina 387
VN - Vietnam 363
BR - Brasile 355
IT - Italia 295
UA - Ucraina 157
DE - Germania 133
FR - Francia 86
AT - Austria 78
SN - Senegal 77
IN - India 73
HK - Hong Kong 66
FI - Finlandia 61
AR - Argentina 57
SE - Svezia 48
CA - Canada 47
BD - Bangladesh 45
GB - Regno Unito 44
KR - Corea 42
TR - Turchia 39
MX - Messico 35
EC - Ecuador 31
IQ - Iraq 27
JP - Giappone 23
CO - Colombia 22
PK - Pakistan 22
RU - Federazione Russa 22
VE - Venezuela 21
ZA - Sudafrica 21
ID - Indonesia 19
MA - Marocco 16
CL - Cile 14
NL - Olanda 13
UZ - Uzbekistan 13
CZ - Repubblica Ceca 12
PY - Paraguay 11
TN - Tunisia 10
AE - Emirati Arabi Uniti 8
AU - Australia 8
SA - Arabia Saudita 8
AL - Albania 7
EG - Egitto 7
JO - Giordania 7
KE - Kenya 7
PH - Filippine 7
BE - Belgio 6
BO - Bolivia 6
IE - Irlanda 6
KZ - Kazakistan 6
LT - Lituania 6
PE - Perù 6
UY - Uruguay 6
CH - Svizzera 5
ES - Italia 5
GR - Grecia 5
MY - Malesia 5
OM - Oman 5
PL - Polonia 5
CR - Costa Rica 4
IL - Israele 4
NP - Nepal 4
PS - Palestinian Territory 4
SV - El Salvador 4
BH - Bahrain 3
BY - Bielorussia 3
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
MK - Macedonia 3
TH - Thailandia 3
TW - Taiwan 3
AM - Armenia 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
NI - Nicaragua 2
PA - Panama 2
RO - Romania 2
SY - Repubblica araba siriana 2
AZ - Azerbaigian 1
BJ - Benin 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
LV - Lettonia 1
ME - Montenegro 1
MU - Mauritius 1
NC - Nuova Caledonia 1
NG - Nigeria 1
Totale 5.826
Città #
Singapore 395
Chandler 279
San Jose 166
Boardman 151
Ashburn 134
Ho Chi Minh City 134
Dallas 121
Beijing 101
Jacksonville 88
New York 85
San Mateo 82
Dakar 77
Hanoi 71
Hong Kong 62
Vienna 60
Helsinki 56
Lauterbourg 48
Hefei 43
Shanghai 43
Seoul 39
Lawrence 36
Roxbury 36
São Paulo 35
Rende 34
Dearborn 31
Los Angeles 30
Brooklyn 27
Ottawa 26
Cosenza 24
Guangzhou 24
Des Moines 23
Cambridge 21
Tokyo 21
Da Nang 20
Ogden 20
Falkenstein 18
Rome 17
Biên Hòa 15
Catanzaro 14
Orem 14
Afyonkarahisar 13
Ann Arbor 13
Baghdad 13
Guayaquil 13
Catania 12
Florence 12
Izmir 12
Mumbai 12
Wilmington 12
Chennai 11
Council Bluffs 11
Haiphong 11
Pune 11
Hải Dương 10
Tashkent 10
West Jordan 10
Brno 9
Milan 9
Nuremberg 9
Quito 9
Redwood City 9
Rio de Janeiro 9
Santa Clara 9
Belo Horizonte 8
Inglewood 8
Lamezia Terme 8
Seattle 8
Thái Bình 8
Tianjin 8
Cape Town 7
Caracas 7
Frankfurt am Main 7
London 7
Manchester 7
Mexico City 7
Montreal 7
Munich 7
Nairobi 7
Phoenix 7
Porto Alegre 7
Toronto 7
Amman 6
Basingstoke 6
Bogotá 6
Boston 6
Brussels 6
Casablanca 6
Chicago 6
Goiânia 6
Guardavalle 6
Johannesburg 6
Medellín 6
Montevideo 6
Naples 6
San Francisco 6
Washington 6
Wuhan 6
Amsterdam 5
Atlanta 5
Buenos Aires 5
Totale 3.213
Nome #
Nanotechnology-based deliviery system of bergamot essential oil, method of preparation of the system and uses thereof. 240
Bergamot essential oil attenuates anxiety-like behaviour in rats 201
Aging brain: In search for better neurotherapeutics 191
Antinociceptive effect of inhalation of the essential oil of bergamot in mice 179
Ageing affects nociception in C57BL/6 mice. 162
Book of Abstracts – Aging Brain: In Search for Better Neurotherapeutics. 161
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Clinical Evidence and Possible Mechanisms 159
Book of Abstracts – Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation. 146
Book of Abstracts - NEW TRENDS IN PAIN RESEARCH From Basic Research to Clinical Translation 132
Benefits and risks associated with cannabis and cannabis derivatives use 128
Opioids Resistance in Chronic Pain Management 126
Pharmacological basis for the treatment of Behavioural and Psychological Symptoms of Dementia (BPSDs) With Aromatherapy 124
Spinal expression of autophagic markers following intraplantar formalin injection 118
Characterization of alpha2-delta1 expression and response to chronic treatment with gabapentin in a mouse model of neuropathic pain. 118
Aging Brain: In Search of Better Neurotherapeutics 117
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety 112
Role of mGlu-5 and mGlu2/3 receptors in behavioural effects of bergamot essential oil 110
Genetic variants of CGRP signaling pathway in migraine: impact on novel therapeutics 109
Anxiolytic-like/relaxant effects of BEO are useful to manage anxiety and agitation symptoms observed in patients with dementia 108
Innovazione farmacoterapeutica necessaria nella gestione dei behavioral and psychological symptoms nella demenza. 108
Pharmacotechnological Advances for Clinical Translation of Essential Oils for the Treatment of Pain and Agitation in Severe Dementia 106
Involvment of metabotropic glutamate receptors in behavioural effects of bergamot essential oil 106
Characterization of mechanical and thermal nociception in ageing mice. 105
Pain assessment for better pharmacological treatment of pain and agitation in severe dementia: I-MOBID2 validation. 103
Characterisation of pain sensitivity in ageing mice 103
Motor behavior induced by bergamot essential oil in experimental tasks is differentially modulated by pretreatment with metabotropic glutamate receptor 2/3 or 5 antagonists 102
Behavioral and psychological symptoms of dementia (BPSD): evidence on pharmacoutilization from a large sample in the real-world setting 99
The need for better access to pain treatment: learning from drug consumption trends in the USA 97
Gender differences in pain response to peripheral injury in mice. 95
Trattamento dei pazienti affetti da demenza in un real-world setting della regione Calabria: gestione dei sintomi comportamentali e del dolore. 94
Eptinezumab for the treatment of migraine 93
Need for a clinical trial investigating efficacy and safety of oral spray nabiximols for pain and agitation treatment in severe dementia patients. 91
TRANSLATION OF BERGAMOT ESSENTIAL OIL IN CLINICAL TRIAL FOR CONTROL OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA 91
Pharmacoepidemiology evidence in favour of a reduced access to pain treatment in patients assuming acetylcholinesterase inhibitors and memantine in the provincial health district of Cosenza . 91
CANNABIS UPDATE 2.0 90
Evidenze farmacoepidemiologiche a favore di un ridotto accesso alla cura del dolore in pazienti trattati con inibitori delle colinesterasi e memantina nel territorio dell’Azienda Sanitaria Provinciale di Cosenza. 90
Validation of an international pain assessment tool to improve pharmacological treatment of pain and agitation in severe dementia. 89
Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy 89
Current opportunities for drug repurposing in pain management: is there a role for autophagy modulation? 89
Indagine farmacoepidemiologica sul trattamento antidolorifico dei pazienti affetti da demenza in Calabria. 88
Translation of bergamot essential oil in clinical trial for control of behavioral and psychological symptoms of dementia (BPSD) 83
Real-world evidence supports combination therapy with anti-CGRP mAbs and onabotulinumtoxinA for chronic migraine 80
New trends in pain research: From basic research to clinical translation 78
Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study 76
Neuropsychiatric symptoms of dementia: role of pain and essential oil of bergamot as a novel therapeutic. 76
Basi razionali per la traslazione clinica dell’olio essenziale di bergamotto. 74
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems 73
Pharmacoutilization data-driven AI-assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia 72
GABAA/Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-like Behaviour in Female Rats 72
Influence of aging on nociception in C57BL/6 mice. 70
Evidence from the real-world of limited access to pain treatment in a large sample of patients suffering from dementia. 68
Neuropharmacology of behavioral disorders in dementia. 60
Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders 58
Evaluation of putative differences in vessel density and flow area in normal tension and high-pressure glaucoma using OCT-angiography 57
Gas Chromatography–Mass Spectroscopy ( GC – MS ) Simultaneous Determination of Limonene, Linalool, and Linalyl Acetate in Rat Plasma Following Transdermal Administration of the Essential Oil of Bergamot Loaded Onto Solid Lipid Nanoparticles ( NanoBEO ) 46
R&D of an essential oil in dementia: the case model of Bergamot 46
Dolore. 42
Targeting pain to control neuropsychiatric symptoms of dementia: the need for tailored clinical trials. 38
Neuropharmacology of the neuropsychiatric symptoms of dementia: possible targets for novel therapeutic approaches 19
NANOTECHNOLOGY-BASED DELIVERY SYSTEM OF BERGAMOT ESSENTIAL OIL, METHOD OF PREPARATION OF THE SYSTEM AND USES THEREOF 12
Hericenone C exhibits anti-nociceptive effects through RORα-mediated suppression of TLR4 transcription 11
Totale 5.971
Categoria #
all - tutte 33.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.334


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 0 0 0 0 34 0 21
2021/2022475 1 33 5 4 34 30 61 89 19 26 54 119
2022/2023665 68 76 35 88 52 63 21 105 65 20 46 26
2023/2024587 45 31 33 25 33 114 23 27 64 29 37 126
2024/2025946 67 130 40 55 67 85 39 46 147 31 94 145
2025/20262.778 299 183 208 252 603 258 299 171 244 261 0 0
Totale 5.971